AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series

One of the most prevalent neurological impairments is cerebrovascular accident (CVA). Ischemic stroke and CVST have been linked to the AstraZeneca COVID‐19 vaccine. Three Sudanese patients developed these diseases after receiving the AstraZeneca COVID‐19 vaccine, indicating a relationship between th...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddig, Amira, Abbasher Hussien Mohamed Ahmed, Khabab, Hassan Haroun, Mazin S., M. Abdallah, Abdallah, Malekaldar, Mohamed, Abbasher, Al Hussien, Abbasher, Mohammed, Abbasher, Abubaker Alsedig, Hussien, Abbasher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272208/
https://www.ncbi.nlm.nih.gov/pubmed/35846901
http://dx.doi.org/10.1002/ccr3.6017
_version_ 1784744844310085632
author Siddig, Amira
Abbasher Hussien Mohamed Ahmed, Khabab
Hassan Haroun, Mazin S.
M. Abdallah, Abdallah
Malekaldar, Mohamed
Abbasher, Al Hussien
Abbasher, Mohammed
Abbasher, Abubaker Alsedig
Hussien, Abbasher
author_facet Siddig, Amira
Abbasher Hussien Mohamed Ahmed, Khabab
Hassan Haroun, Mazin S.
M. Abdallah, Abdallah
Malekaldar, Mohamed
Abbasher, Al Hussien
Abbasher, Mohammed
Abbasher, Abubaker Alsedig
Hussien, Abbasher
author_sort Siddig, Amira
collection PubMed
description One of the most prevalent neurological impairments is cerebrovascular accident (CVA). Ischemic stroke and CVST have been linked to the AstraZeneca COVID‐19 vaccine. Three Sudanese patients developed these diseases after receiving the AstraZeneca COVID‐19 vaccine, indicating a relationship between the AstraZeneca COVID‐19 vaccine and these conditions.
format Online
Article
Text
id pubmed-9272208
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92722082022-07-15 AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series Siddig, Amira Abbasher Hussien Mohamed Ahmed, Khabab Hassan Haroun, Mazin S. M. Abdallah, Abdallah Malekaldar, Mohamed Abbasher, Al Hussien Abbasher, Mohammed Abbasher, Abubaker Alsedig Hussien, Abbasher Clin Case Rep Case Report One of the most prevalent neurological impairments is cerebrovascular accident (CVA). Ischemic stroke and CVST have been linked to the AstraZeneca COVID‐19 vaccine. Three Sudanese patients developed these diseases after receiving the AstraZeneca COVID‐19 vaccine, indicating a relationship between the AstraZeneca COVID‐19 vaccine and these conditions. John Wiley and Sons Inc. 2022-07-11 /pmc/articles/PMC9272208/ /pubmed/35846901 http://dx.doi.org/10.1002/ccr3.6017 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Siddig, Amira
Abbasher Hussien Mohamed Ahmed, Khabab
Hassan Haroun, Mazin S.
M. Abdallah, Abdallah
Malekaldar, Mohamed
Abbasher, Al Hussien
Abbasher, Mohammed
Abbasher, Abubaker Alsedig
Hussien, Abbasher
AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series
title AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series
title_full AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series
title_fullStr AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series
title_full_unstemmed AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series
title_short AstraZeneca COVID‐19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series
title_sort astrazeneca covid‐19 vaccine: a possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: a case series
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272208/
https://www.ncbi.nlm.nih.gov/pubmed/35846901
http://dx.doi.org/10.1002/ccr3.6017
work_keys_str_mv AT siddigamira astrazenecacovid19vaccineapossibleriskfactorforischemicstrokeandcerebralvenoussagittalsinusthrombosisacaseseries
AT abbasherhussienmohamedahmedkhabab astrazenecacovid19vaccineapossibleriskfactorforischemicstrokeandcerebralvenoussagittalsinusthrombosisacaseseries
AT hassanharounmazins astrazenecacovid19vaccineapossibleriskfactorforischemicstrokeandcerebralvenoussagittalsinusthrombosisacaseseries
AT mabdallahabdallah astrazenecacovid19vaccineapossibleriskfactorforischemicstrokeandcerebralvenoussagittalsinusthrombosisacaseseries
AT malekaldarmohamed astrazenecacovid19vaccineapossibleriskfactorforischemicstrokeandcerebralvenoussagittalsinusthrombosisacaseseries
AT abbasheralhussien astrazenecacovid19vaccineapossibleriskfactorforischemicstrokeandcerebralvenoussagittalsinusthrombosisacaseseries
AT abbashermohammed astrazenecacovid19vaccineapossibleriskfactorforischemicstrokeandcerebralvenoussagittalsinusthrombosisacaseseries
AT abbasherabubakeralsedig astrazenecacovid19vaccineapossibleriskfactorforischemicstrokeandcerebralvenoussagittalsinusthrombosisacaseseries
AT hussienabbasher astrazenecacovid19vaccineapossibleriskfactorforischemicstrokeandcerebralvenoussagittalsinusthrombosisacaseseries

Ejemplares similares